Members of the Animal Health Institute (AHI) and the Generic Animal Drug Alliance (GADA) today announced their written commitments to align all affected products with the Food and Drug Administration’s (FDA) policy on judicious use of antibiotics. Under the policy, the growth promotion uses of medically important compounds will be phased out and veterinary oversight of the use of therapeutic products will be phased in.
FDA stated it anticipates the new policy will be fully phased in over the next three years and originally asked companies to communicate their intentions to the agency within 90 days from December 12, 2013, when Final Guidance 213 was announced.
